Several of our Advocate Collaborative members have helped to design an anonymous survey on treatment choices for individuals with HER2+ metastatic breast cancer, regardless of hormone-receptor status, in the US. […]
Several of our Advocate Collaborative members have helped to design an anonymous survey on treatment choices for individuals with HER2+ metastatic breast cancer, regardless of hormone-receptor status, in the US. […]